NVS Option Call 18-07-2025 105 Option on Novartis AG ADR
NVS Stock | USD 99.17 0.96 0.96% |
NVS Option Call 18-07-2025 105 is a CALL option contract on Novartis' common stock with a strick price of 105.0 expiring on 2025-07-18. The contract was last traded on 2024-12-09 at 12:39:43 for $4.3 and, as of today, has 219 days remaining before the expiration. The option is currently trading at an ask price of $0.0. The implied volatility as of the 11th of December 2024 is 219.0.
Novartis |
Call options on Novartis give the investor right to buy Novartis Stock at a specified price within a specific period. If Novartis' price is above the strike price at expiry, the profit is the current Novartis' stock price, minus the strike price and the premium.
Rule 16 of 2025-07-18 Option Contract
The options market is anticipating that Novartis AG ADR will have an average daily up or down price movement of about 9.77E-4% per day over the life of the option. With Novartis trading at USD 99.17, that is roughly USD 9.69E-4. If you think that the market is fully understating Novartis' daily price movement you should consider buying Novartis AG ADR options at that current volatility level of 0.0156%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Out Of The Money Call Option on Novartis
An 'Out of The Money' option on Novartis has a strike price that Novartis Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Novartis' 'Out of The Money' options include buying the options if you expect a big move in Novartis' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Call Contract Name | NVS Option Call 18-07-2025 105 |
Expires On | 2025-07-18 |
Days Before Expriration | 219 |
Last Traded On | 2024-12-09 12:39:43 |
Open Interest | 138 |
Current Trading Volume | 1.0 |
Strike Price | 105.0 |
Last Traded At | 4.3 |
Current Price Spread | 0.0 | 0.0 |
Rule 16 Daily Up or Down | USD 9.69E-4 |
Novartis long CALL Option Payoff at expiration
Buying Novartis' call option is the simplest of option trades. A call option on Novartis Stock gives investors the right (but not the obligation) to purchase Novartis at the given strike price. Therefore Novartis' call intrinsic value or payoff at expiration depends on where the Novartis Stock price is relative to the call option strike price. The strike price of 105.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and negative (the trade is a loss). Above the strike, the payoff line is upward sloping as the option payoff rises in proportion with Novartis' price. Finally, at the break-even point of 105.0, the line crosses zero, and trading Novartis becomes profitable.
Profit |
Novartis Price At Expiration |
Novartis short CALL Option Payoff at expiration
By selling Novartis' call option, the investors signals his or her bearish sentiment. A short position in a call option written on Novartis will generally make money when the underlying price goes down. Therefore Novartis' call intrinsic value or payoff at expiration depends on where the Novartis Stock price is relative to the call option strike price. The strike price of 105.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and positive (the seller makes a profit). Above the strike, the payoff line is downward sloping as the option payoff drops in proportion to Novartis' price. Finally, at the break-even point of 105.0, the line crosses zero, and trading Novartis becomes disadvantageous with no downside limits.
Profit |
Novartis Price At Expiration |
Novartis AG ADR Available Call Options
Novartis' option chain is a display of a range of information that helps investors for ways to trade options on Novartis. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Novartis. It also shows strike prices and maturity days for a Novartis against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Expiration | Current Spread | Last Price | |||
Call | NVS Option Call 20-12-2024 95 | 12 | 2024-12-20 | 0.0 - 0.0 | 6.4 | In |
Call | NVS Option Call 20-12-2024 100 | 109 | 2024-12-20 | 0.0 - 0.0 | 1.79 | Out |
Call | NVS Option Call 20-12-2024 105 | 448 | 2024-12-20 | 0.0 - 0.0 | 0.2 | Out |
Call | NVS Option Call 20-12-2024 110 | 574 | 2024-12-20 | 0.0 - 0.0 | 0.1 | Out |
Call | NVS Option Call 20-12-2024 115 | 223 | 2024-12-20 | 0.0 - 0.0 | 0.05 | Out |
Call | NVS Option Call 20-12-2024 120 | 267 | 2024-12-20 | 0.0 - 0.0 | 0.02 | Out |
Call | NVS Option Call 20-12-2024 125 | 64 | 2024-12-20 | 0.0 - 0.95 | 0.15 | Out |
Call | NVS Option Call 20-12-2024 130 | 0 | 2024-12-20 | 0.0 - 0.75 | 0.1 |
Novartis Corporate Directors
Ton Buechner | Non-Executive Independent Director | Profile | |
Frans Houten | Non-Executive Independent Director | Profile | |
Nancy Andrews | Non-Executive Independent Director | Profile | |
Elizabeth Doherty | Non-Executive Independent Director | Profile |
Additional Tools for Novartis Stock Analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.